서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 10 of 10

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2009-05	Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: A retrospective analysis Han, Jung Ho; Park, Chul-Kee; Lee, Se-Hoon; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won Chemotherapy, Vol.55 No.3, pp.145-154	DOI
2009-08	Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin Park, Chul-Kee; Park, Sung-Hye; Lee, Se-Hoon; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won Neuropathology, Vol.29 No.4, pp.443-449	DOI
2009-12	Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy Park, Chul-Kee; Lee, Se-Hoon; Han, Jung Ho; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won BMC Cancer, Vol.9, p. 450	DOI
2010-12	The effect of brain atrophy on outcome after a large cerebral infarction Lee, Sang Hyung; Oh, Chang Wan; Han, Jung Ho; Kim, Chae-Yong; Kwon, O-Ki; Son, Young-Je; Bae, Hee-Joon; Han, Moon-Ku; Chung, Young Seob Journal of Neurology, Neurosurgery and Psychiatry, Vol.81 No.12, pp.1316-1321	DOI
2011-07	Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial Kim, Il Han; Park, Chul-Kee; Heo, Dae Seog; Kim, Chae-Yong; Rhee, Chang Hun; Nam, Do-Hyun; Lee, Seung Hoon; Han, Jung Ho; Lee, Se-Hoon; Kim, Tae Min; Kim, Dong-Wan; Kim, Jeong Eun; Paek, Sun Ha; Kim, Dong Gyu; Kim, In Ah; Kim, Yu Jung; Kim, Jee Hyun; Park, Byung-Joo; Jung, Hee-Won Journal of Neuro-Oncology, Vol.103 No.3, pp.595-602	DOI
2017-01	Post-bevacizumab clinical outcomes and the impact of early discontinuation of bevacizumab in patients with recurrent malignant glioma Cha, Yongjun; Kim, Yu Jung; Lee, Se-Hoon; Kim, Tae-Min; Choi, Seung Hong; Kim, Dong-Wan; Park, Chul-Kee; Kim, Il Han; Kim, Jee Hyun; Kim, Eunhee; Choi, Byungse; Kim, Chae-Yong; Kim, In Ah; Heo, Dae Seog Cancer Research and Treatment, Vol.49 No.1, pp.129-140	DOI
2018-11	Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: A single institutional cohort Jeon, Wan; Jang, Bum-Sup; Jeon, Seung Hyuck; Kim, Jee Hyun; Kim, Yu Jung; Kim, Se Hyun; Kim, Chae-Yong; Han, Jung Ho; Kim, In Ah Breast Journal, Vol.24 No.6, pp.920-926	DOI
2020-06	Predictors of pre-operative cognitive impairment in meningioma patients over 60 years old Kang, Min J; Pyun, Jung-Min; Baek, Min J; Hwang, Kihwan; Han, Jung H; Park, Young H; Kim, Chae-Yong; Kim, SangYun BMC Neurology. 2020 Jun 03;20(1):225	view file link
2022-06	Clinicopathologic Characteristics of Grade 2/3 Meningiomas: A Perspective on the Role of Next-Generation Sequencing Kim, Junhyung; Hwang, Kihwan; Kwon, Hyun Jung; Lee, Ji Eun; Lee, Kyu Sang; Choe, Gheeyoung; Han, Jung Ho; Kim, Chae-Yong Frontiers in Oncology, Vol.12, p. 885155	DOI
2022-07	Adjuvant Radiotherapy Versus Surveillance for Grade 2 Intracranial Meningiomas: A Multi-Institutional Propensity Score-Matched Study Byun, Hwa Kyung; Chang, Won Ick; Lee, Joo Ho; Park, Chul-Kee; Kim, In Ah; Kim, Chae-Yong; Cho, Jaeho; Kim, Eui Hyun; Chang, Jong Hee; Kang, Seok-Gu; Moon, Ju Hyung; Lee, Sang Hyung; Lee, Jason Joon Bock; Kim, Il Han; Suh, Chang-Ok; Wee, Chan Woo; Yoon, Hong In Frontiers in Oncology, Vol.12, p. 877244	DOI

1